Geode Capital Management LLC Grows Stake in The Clorox Company (NYSE:CLX)

Geode Capital Management LLC boosted its position in shares of The Clorox Company (NYSE:CLXGet Rating) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,331,231 shares of the company’s stock after purchasing an additional 54,921 shares during the quarter. Geode Capital Management LLC’s holdings in Clorox were worth $405,639,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Dark Forest Capital Management LP purchased a new position in shares of Clorox in the 3rd quarter valued at $25,000. Eagle Bay Advisors LLC purchased a new position in shares of Clorox in the 3rd quarter valued at $26,000. Newbridge Financial Services Group Inc. increased its holdings in shares of Clorox by 185.2% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 154 shares of the company’s stock valued at $27,000 after acquiring an additional 100 shares during the period. TAP Consulting LLC purchased a new position in shares of Clorox in the 4th quarter valued at $27,000. Finally, FSB Premier Wealth Management Inc. purchased a new position in shares of Clorox in the 4th quarter valued at $28,000. Institutional investors own 77.28% of the company’s stock.

In other Clorox news, COO Eric H. Reynolds sold 585 shares of the business’s stock in a transaction that occurred on Monday, May 9th. The stock was sold at an average price of $154.83, for a total transaction of $90,575.55. Following the completion of the sale, the chief operating officer now directly owns 17,289 shares in the company, valued at approximately $2,676,855.87. The transaction was disclosed in a document filed with the SEC, which is available through this link. 0.58% of the stock is owned by insiders.

Shares of Clorox stock opened at $139.59 on Tuesday. The company has a quick ratio of 0.40, a current ratio of 0.71 and a debt-to-equity ratio of 3.28. The Clorox Company has a twelve month low of $127.02 and a twelve month high of $191.75. The business has a 50-day moving average price of $144.77 and a 200 day moving average price of $156.51. The firm has a market cap of $17.18 billion, a PE ratio of 37.83, a P/E/G ratio of 4.74 and a beta of 0.18.

Clorox (NYSE:CLXGet Rating) last announced its quarterly earnings results on Monday, May 2nd. The company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.34. Clorox had a return on equity of 92.98% and a net margin of 6.44%. The firm had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the previous year, the business earned $1.62 EPS. On average, sell-side analysts expect that The Clorox Company will post 4.16 EPS for the current year.

A number of research analysts have recently issued reports on the company. DA Davidson cut their price target on Clorox from $127.00 to $123.00 in a report on Tuesday, May 3rd. Barclays dropped their target price on Clorox from $126.00 to $115.00 and set an “underweight” rating on the stock in a research note on Monday. JPMorgan Chase & Co. boosted their target price on Clorox from $123.00 to $126.00 in a research note on Thursday, April 14th. Credit Suisse Group dropped their target price on Clorox from $160.00 to $155.00 and set an “underperform” rating on the stock in a research note on Friday, February 4th. Finally, Morgan Stanley dropped their target price on Clorox from $154.00 to $140.00 and set an “underweight” rating on the stock in a research note on Friday, February 4th. Ten analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Clorox presently has an average rating of “Sell” and an average price target of $141.21.

Clorox Company Profile (Get Rating)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXGet Rating).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.